Author

R. Almeida

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. Abrunhosa· 1 shared A. Buhles· 1 shared A. Louzolo· 1 shared A. Olsson· 1 shared A. Paiva· 1 shared A. S. Ribeiro· 1 shared A. Weiss· 1 shared C. Gomes· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Abrunhosa

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodeling

S. Almeida, L. Santos, G. Ribeiro, H. Ferreira, N. Lima, R. Caetano, M. Abreu, M. Zuzarte, A. S. Ribeiro, A. Paiva, T. Martins-Marques, P. Teixeira, R. Almeida, J. Casanova, H. Girao, , C. Gomes

The paper investigates how osteosarcoma secretome remodels the lung microenvironment to promote metastasis using mouse models and multi-omics analysis.

bioRxiv · May 6, 2023Cancer Biology

Therapeutic assessment of targeting ASNS combined with L-Asparaginase treatment in solid tumors and investigation of resistance mechanisms

V. Apfel, D. Begue, V. Cordo, L. Holzer, L. Martinuzzi, A. Buhles, G. Kerr, I. Barbosa, U. Naumann, M. Piquet, D. Ruddy, A. Weiss, S. Ferretti, R. Almeida, D. Bonenfant, , G. G. Galli

This study assesses targeting ASNS with L-Asparaginase in solid tumors, identifies resistance mechanisms, and proposes therapeutic combinations.

bioRxiv · Sep 8, 2020Cancer Biology

CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients

C. Pereira, D. Ferreira, C. Lemos, D. Martins, N. Mendes, D. Almeida, P. Granja, F. Carneiro, R. Almeida, G. M. Almeida, C. Oliveira

This study identifies CD44v6 expression as a predictor of therapy response and poor prognosis in gastric cancer patients, showing higher expression correlates with worse outcomes and benefit from chemotherapy.

bioRxiv · Nov 30, 2018 · PreprintCancer Biology

Enhanced instructed fear learning in delusion-proneness

P. Petrovic, A. Louzolo, R. Almeida, M. Guitart-Masip, M. Björnsdotter, M. Ingvar, A. Olsson

This study shows delusion-prone individuals exhibit stronger instructed fear learning and lateral orbitofrontal cortex activation compared to controls, suggesting coexistence of strong top-down and weak bottom-up learning in psychosis-associated states.

bioRxiv · Feb 20, 2018Physiology